Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3280416
Title:
SCHEMA DE TRAITEMENT EN CAS DE DOSES OUBLIEES POUR DES ESTERS DE PALIPERIDONE INJECTABLES A ACTION PROLONGEE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
167770585
WO application number:
US2016024841
Type:
European patent granted for BE
Status:
Open
Publication number:
3280416
WO publication number:
WO2016164218
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
30/03/2016
Grant date:
22/04/2020
EP publication date:
14/02/2018
WO publication date:
13/10/2016
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/04/2020
EP B1 publication date:
22/04/2020
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
30/03/2036
Applicant
1
Name:
Janssen Pharmaceutica NV
Legal Form:
From:
23/07/2021
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
To:
2
Name:
Janssen Pharmaceuticals, Inc.
Legal Form:
From:
22/04/2020
Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States (US)
To:
23/07/2021
Agent
1
Name:
KORSTEN Marius
Legal Form:
From:
12/12/2024
Address:
New Babylon City Offices
Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)